general practitioner	Other
cornerstone	Other
preliminary result	Other
New digital technology	Other
access	first-onset
cognitive-behavioural therapy	complement
cognitive-behavioural therapy	hippocampal
cognitive-behavioural therapy	Demoralization
cognitive-behavioural therapy	ECT
cognitive-behavioural therapy	reported
significant room	complement
isolate disease	lithium
syndrome	Other
apomorphine	apomorphine
its use	first-onset
its use	hippocampal
its use	EDT
its use	psychotropics
its use	reported
its use	death
its use	mood
dopaminergic agonist	Demoralization
apomorphine	apomorphine
connection	Other
structure	Other
we	Other
progressive neuropathic change	addiction
progressive neuropathic change	fear
progressive neuropathic change	framework
progressive neuropathic change	fasting
progressive neuropathic change	design
benefit	biomarker
experience	Other
study	electronic
physical activity	biomarker
physical activity	hippocampal
Accredited Exercise Physiologists	Other
early intervention	electronic
General practitioner	Other
patient	design
psychiatric outpatient clinic	design
psychiatric outpatient clinic	stimulation
this	Other
long-term health-related quality	first-onset
long-term health-related quality	hippocampal
long-term health-related quality	death
long-term health-related quality	mood
long-term health-related quality	lithium
anorexia nervosa	Other
long-term prognosis	Other
family	Other
therapy	Other
objective	Other
talk therapy	Other
treatment utilization	first-onset
treatment utilization	hippocampal
treatment utilization	stimulation
treatment utilization	psychotropics
treatment utilization	reported
treatment utilization	death
treatment utilization	mood
therapy	Other
we	Other
depression patient	complement
depression patient	design
resting-state functional magnetic resonance imaging	addiction
resting-state functional magnetic resonance imaging	fear
resting-state functional magnetic resonance imaging	health-based
resting-state functional magnetic resonance imaging	fasting
resting-state functional magnetic resonance imaging	design
resting-state functional magnetic resonance imaging	lithium
functional connectivity strength	Other
fcs	Other
change fcs	addiction
change fcs	fear
change fcs	framework
change fcs	fasting
change fcs	design
ECT	CYB5R3
ECT	apomorphine
ECT	ECT
anxiety disorder	hippocampal
anxiety disorder	psychotropics
anxiety disorder	reported
anxiety disorder	death
anxiety disorder	lithium
they	Other
deveau	Other
author	Other
they	Other
implication	Other
future research	apomorphine
positive aspect use	first-onset
positive aspect use	hippocampal
positive aspect use	EDT
positive aspect use	psychotropics
positive aspect use	reported
positive aspect use	death
positive aspect use	mood
most college student	first-onset
most college student	EDT
most college student	mood
it	Other
lithium	biomarker
lithium	lithium
lithium	biomarker
lithium	lithium
we	Other
we	Other
finding	Other
lithium	biomarker
lithium	lithium
validation	Other
we	Other
first evidence	biomarker
first evidence	addiction
first evidence	fear
first evidence	framework
first evidence	fasting
first evidence	design
brief Services psychotherapy paradigm	Other
its clinical evaluation	complement
its clinical evaluation	hippocampal
its clinical evaluation	stimulation
its clinical evaluation	psychotropics
its clinical evaluation	reported
its clinical evaluation	death
its clinical evaluation	mood
individual	Other
quality	death
nih-funded randomize clinical trial	complement
nih-funded randomize clinical trial	hippocampal
nih-funded randomize clinical trial	stimulation
nih-funded randomize clinical trial	psychotropics
nih-funded randomize clinical trial	reported
nih-funded randomize clinical trial	death
nih-funded randomize clinical trial	mood
dysregulation	Other
alteration	Other
we	Other
we	Other
Study quality	death
twenty-five study	electronic
biomarker assessment methodology	biomarker
biomarker assessment methodology	apomorphine
biomarker assessment methodology	health-based
biomarker assessment methodology	lithium
meta-analytical computation	lithium
Study characteristic	Other
biomarker confounder consideration rating	biomarker
we	Other
literature	lithium
improving communication	Other
communication	Other
second-level intervention	Other
disorder	hippocampal
disorder	reported
disorder	death
assist outpatient treatment	first-onset
assist outpatient treatment	hippocampal
assist outpatient treatment	design
assist outpatient treatment	stimulation
assist outpatient treatment	psychotropics
assist outpatient treatment	reported
assist outpatient treatment	death
assist outpatient treatment	mood
goal	Other
Parkinson 's disease	lithium
molecular imaging	CYB5R3
molecular imaging	ECT
chapter	Other
we	Other
hiv-1-infected patient	design
suicide rate	Other
study	electronic
datum	Other
patient	design
severity indicator	CYB5R3
related symptom	first-onset
related symptom	hippocampal
difficulty	Other
mental health treatment	first-onset
mental health treatment	hippocampal
mental health treatment	stimulation
mental health treatment	psychotropics
mental health treatment	reported
mental health treatment	death
mental health treatment	mood
mental health treatment	lithium
eating-disorder psychopathology	CYB5R3
eating-disorder psychopathology	hippocampal
eating-disorder psychopathology	EDT
eating-disorder psychopathology	stimulation
eating-disorder psychopathology	reported
eating-disorder psychopathology	death
eating-disorder psychopathology	mood
athlete	lithium
individual	Other
most ed assessment	apomorphine
most ed assessment	health-based
purpose	Other
avoidant/restrictive food intake disorder	hippocampal
avoidant/restrictive food intake disorder	stimulation
avoidant/restrictive food intake disorder	reported
avoidant/restrictive food intake disorder	death
severity	CYB5R3
we	Other
use	first-onset
use	hippocampal
use	EDT
use	psychotropics
use	reported
use	death
use	mood
purpose	Other
damaging outcome	Other
we study	electronic
extensive research	Other
neuroimaging	Other
reduction	Other
hiv protein	Other
complement	complement
complement	apomorphine
c1qa knockout mouse	first-onset
c1qa knockout mouse	hippocampal
c1qa knockout mouse	EDT
c1qa knockout mouse	psychotropics
c1qa knockout mouse	reported
c1qa knockout mouse	death
c1qa knockout mouse	mood
subcallosal cingulate	Other
New development	biomarker
New development	complement
we	Other
activation	apomorphine
regressor	Other
left cb	Other
recovery process	Other
sex difference	Other
preclinical study	electronic
preclinical study	complement
preclinical study	hippocampal
preclinical study	stimulation
preclinical study	psychotropics
preclinical study	reported
preclinical study	death
preclinical study	mood
depression	complement
rat	Other
treatment effect	first-onset
treatment effect	hippocampal
treatment effect	stimulation
treatment effect	psychotropics
treatment effect	reported
treatment effect	death
treatment effect	mood
chronic 17β-estradiol treatment	first-onset
chronic 17β-estradiol treatment	hippocampal
chronic 17β-estradiol treatment	stimulation
chronic 17β-estradiol treatment	psychotropics
chronic 17β-estradiol treatment	reported
chronic 17β-estradiol treatment	death
chronic 17β-estradiol treatment	mood
article	Other
few study	electronic
purpose	Other
treatment outcome	first-onset
treatment outcome	hippocampal
treatment outcome	stimulation
treatment outcome	psychotropics
treatment outcome	reported
treatment outcome	death
treatment outcome	mood
mood disorder	components
mood disorder	hippocampal
mood disorder	reported
mood disorder	death
mood disorder	mood
major depressive disorder	hippocampal
major depressive disorder	reported
major depressive disorder	death
exist pharmacological treatment	first-onset
exist pharmacological treatment	hippocampal
exist pharmacological treatment	stimulation
exist pharmacological treatment	psychotropics
exist pharmacological treatment	reported
exist pharmacological treatment	death
exist pharmacological treatment	mood
cognitive function	complement
cognitive function	hippocampal
cognitive function	ECT
cognitive function	reported
neural basis	psychotropics
molecular mechanism	CYB5R3
molecular mechanism	complement
molecular mechanism	stimulation
molecular mechanism	ECT
aim	Other
we	Other
cognitive deficit	complement
cognitive deficit	hippocampal
cognitive deficit	ECT
cognitive deficit	reported
develop area	Other
proportion	Other
sporadic creutzfeldt-jakob disease	lithium
it	Other
key event	EDT
pq912	Other
we	Other
aim	Other
exploratory efficacy readout	complement
therapeutic approach	ECT
antipsychotic monotherapy	complement
antipsychotic polypharmacy	complement
membrane-bound nadh-dependent redox enzyme	Other
incurable disease	lithium
cholesterol biosynthesis	Other
cyb5r3 deficiency	Other
its role	Other
its role	Other
type ii rhm	electronic
type ii rhm	apomorphine
type ii rhm	components
neurological symptom	Other
homelessness	CYB5R3
child	CYB5R3
we	Other
use	first-onset
use	hippocampal
use	EDT
use	psychotropics
use	reported
use	death
use	mood
Methylphenidate	lithium
%	Other
use	first-onset
use	hippocampal
use	EDT
use	psychotropics
use	reported
use	death
use	mood
use	first-onset
use	hippocampal
use	EDT
use	psychotropics
use	reported
use	death
use	mood
psychotropic drug use	first-onset
psychotropic drug use	hippocampal
psychotropic drug use	EDT
psychotropic drug use	psychotropics
psychotropic drug use	reported
psychotropic drug use	death
psychotropic drug use	mood
use	first-onset
use	hippocampal
use	EDT
use	psychotropics
use	reported
use	death
use	mood
psychotropic drug use	first-onset
psychotropic drug use	hippocampal
psychotropic drug use	EDT
psychotropic drug use	psychotropics
psychotropic drug use	reported
psychotropic drug use	death
psychotropic drug use	mood
purpose	Other
death anxiety	components
death anxiety	psychotropics
death anxiety	reported
death anxiety	death
death anxiety	lithium
research	Other
psychosocial treatment	first-onset
psychosocial treatment	hippocampal
psychosocial treatment	stimulation
psychosocial treatment	psychotropics
psychosocial treatment	reported
psychosocial treatment	death
psychosocial treatment	mood
therapy type	electronic
therapy type	apomorphine
therapy type	components
clinical sample	addiction
clinical sample	complement
clinical sample	fear
clinical sample	framework
clinical sample	hippocampal
clinical sample	fasting
clinical sample	design
clinical sample	stimulation
clinical sample	psychotropics
clinical sample	reported
clinical sample	death
clinical sample	mood
grow trend	Other
sub-theme	Other
online community	Other
Collaborative	Other
demoralization	Other
demoralization	Other
measure	Other
we	Other
we result	Other
presence	Other
cognitive deficit	complement
cognitive deficit	hippocampal
cognitive deficit	ECT
cognitive deficit	reported
important role	Other
research	Other
functional ability	Other
functional disability	Other
performance-based functional assessment	CYB5R3
performance-based functional assessment	apomorphine
performance-based functional assessment	health-based
pathogenesis	Other
cocaine	Other
modulation	Other
catb secretion	lithium
pharmacological modulation	Other
hiv-1 seronegative donor	Other
aged patient	hippocampal
aged patient	design
aged patient	stimulation
aged patient	psychotropics
aged patient	reported
aged patient	death
systematic study	electronic
systematic study	lithium
review	Other
gray matter volume	Other
hearing-impairment	Other
association	Other
previous research	Other
high intensity	stimulation
we	Other
clinical high-risk state	complement
clinical high-risk state	fear
clinical high-risk state	hippocampal
clinical high-risk state	fasting
clinical high-risk state	design
clinical high-risk state	stimulation
clinical high-risk state	psychotropics
clinical high-risk state	reported
clinical high-risk state	death
clinical high-risk state	mood
patient	design
diversity	Other
bipolar disorder	hippocampal
bipolar disorder	reported
bipolar disorder	death
case-control study	electronic
Citrus species	Other
treatment	first-onset
treatment	hippocampal
treatment	stimulation
treatment	psychotropics
treatment	reported
treatment	death
treatment	mood
antihyperalgesia	Other
treatment	first-onset
treatment	hippocampal
treatment	stimulation
treatment	psychotropics
treatment	reported
treatment	death
treatment	mood
level	Other
result	Other
purpose	Other
interest	Other
use	first-onset
use	hippocampal
use	EDT
use	psychotropics
use	reported
use	death
use	mood
depression	complement
study	electronic
antepartum depression	complement
aim	Other
update information	components
aim	Other
variation	Other
homeless population	CYB5R3
homeless population	lithium
project	Other
we	Other
Charlson Comorbidity Index	mood
183 homeless patient	CYB5R3
183 homeless patient	design
32.2 %	Other
cci	Other
female	Other
mental health disorder	hippocampal
mental health disorder	reported
mental health disorder	death
mental health disorder	mood
mental health disorder	lithium
homeless woman	CYB5R3
rate	Other
study	electronic
other chronic psychiatric disorder	hippocampal
other chronic psychiatric disorder	stimulation
other chronic psychiatric disorder	reported
other chronic psychiatric disorder	death
other chronic psychiatric disorder	mood
age	hippocampal
age	stimulation
age	psychotropics
age	reported
age	death
epigenetic mechanism	CYB5R3
epigenetic mechanism	complement
epigenetic mechanism	stimulation
epigenetic mechanism	lithium
they	Other
current state	fear
current state	apomorphine
current state	fasting
current state	design
epigenetic alteration	lithium
epigenetic mechanism	CYB5R3
epigenetic mechanism	complement
epigenetic mechanism	stimulation
epigenetic mechanism	lithium
line	Other
Age	Other
relation	components
antipsychotic-naïve schizophrenia patient	complement
antipsychotic-naïve schizophrenia patient	design
antipsychotic-naïve schizophrenia patient	ECT
we	Other
we	Other
study	electronic
non-adherence	Other
patient	design
fear	addiction
fear	fear
fear	framework
fear	health-based
fear	fasting
fear	design
caloric	Other
present study	electronic
present study	psychotropics
twenty-five	Other
change	addiction
change	fear
change	framework
change	fasting
change	design
one-night fasting	addiction
one-night fasting	fear
one-night fasting	framework
one-night fasting	health-based
one-night fasting	fasting
procedure	Other
plasma ghrelin level	Other
fasting	addiction
fasting	fear
fasting	framework
fasting	health-based
fasting	fasting
novel procedure	Other
evidence	biomarker
we	Other
many research question	Other
large datum set	lithium
care-seeking	mood
recent advance	EDT
innovation	Other
Schizophrenia	Other
it	Other
barrier	Other
little	Other
scop review	Other
issue	Other
review	Other
it	Other
aim	Other
significant between-group difference	complement
significant between-group difference	lithium
scientific knowledge	electronic
frontier	Other
we	Other
live space	Other
psychopathological symptom	Other
far-reaching relevance	Other
article	Other
main characteristic	Other
common mental health problem	death
common mental health problem	mood
common mental health problem	lithium
cmhp	Other
intervention	Other
meta-analysis	lithium
meta-analytic procedure	lithium
we	Other
other intervention	Other
Epilepsy	Other
management	hippocampal
management	EDT
management	stimulation
management	psychotropics
management	reported
management	death
Child Sexual abuse	first-onset
Child Sexual abuse	hippocampal
Child Sexual abuse	EDT
Child Sexual abuse	psychotropics
Child Sexual abuse	reported
Child Sexual abuse	death
Child Sexual abuse	mood
we	Other
purpose	Other
alcohol withdrawal	electronic
alcohol withdrawal	stimulation
content validity	Other
Assessment	Other
Tool	addiction
Tool	fear
Tool	framework
Tool	fasting
pregnancy	Other
n	Other
Partner dynamics	Other
result	Other
va reliance	Other
aim	Other
limited number	EDT
magnitude	Other
use	first-onset
use	hippocampal
use	EDT
use	psychotropics
use	reported
use	death
use	mood
animal study	electronic
prevalence rate	Other
Food addiction	addiction
Food addiction	fear
Food addiction	framework
Food addiction	fasting
Food addiction	design
polygenic score	Other
polygenic dopamine score	Demoralization
food addiction	addiction
food addiction	fear
food addiction	framework
food addiction	fasting
food addiction	design
food addiction	stimulation
polygenic score	Other
evidence	biomarker
untreated mental disorder	hippocampal
untreated mental disorder	reported
untreated mental disorder	death
half	Other
early intervention	electronic
atypical antipsychotic	CYB5R3
atypical antipsychotic	complement
treatment	first-onset
treatment	hippocampal
treatment	stimulation
treatment	psychotropics
treatment	reported
treatment	death
treatment	mood
circulate insulin	Other
hypothalamic mif expression	Other
Olanzapine	Other
increase plasma lipid concentration	CYB5R3
mouse	first-onset
mouse	hippocampal
mouse	EDT
mouse	psychotropics
mouse	reported
mouse	death
mouse	mood
finding	Other
health-based electronic game	addiction
health-based electronic game	CYB5R3
health-based electronic game	electronic
health-based electronic game	fear
health-based electronic game	framework
health-based electronic game	components
health-based electronic game	health-based
health-based electronic game	fasting
health-based electronic game	design
health-based electronic game	death
health-based electronic game	mood
health-based electronic game	lithium
design game	addiction
design game	fear
design game	framework
design game	components
design game	health-based
design game	fasting
design game	design
aim	Other
health-based electronic game framework	addiction
health-based electronic game framework	CYB5R3
health-based electronic game framework	electronic
health-based electronic game framework	fear
health-based electronic game framework	framework
health-based electronic game framework	components
health-based electronic game framework	health-based
health-based electronic game framework	fasting
health-based electronic game framework	design
health-based electronic game framework	death
health-based electronic game framework	mood
health-based electronic game framework	lithium
determination	lithium
game framework design	addiction
game framework design	fear
game framework design	framework
game framework design	components
game framework design	health-based
game framework design	fasting
game framework design	design
sample	addiction
sample	fear
sample	framework
sample	fasting
sample	design
important component	Other
axis	Other
application area	Other
sweet care game	addiction
sweet care game	fear
sweet care game	framework
sweet care game	health-based
sweet care game	fasting
sweet care game	design
sweet care game	mood
sweet care game	lithium
health-based electronic game	addiction
health-based electronic game	CYB5R3
health-based electronic game	electronic
health-based electronic game	fear
health-based electronic game	framework
health-based electronic game	components
health-based electronic game	health-based
health-based electronic game	fasting
health-based electronic game	design
health-based electronic game	death
health-based electronic game	mood
health-based electronic game	lithium
anxiety-related disorder	first-onset
anxiety-related disorder	hippocampal
anxiety-related disorder	psychotropics
anxiety-related disorder	reported
anxiety-related disorder	death
anxiety-related disorder	lithium
they	Other
Comprehensive assessment	apomorphine
Comprehensive assessment	health-based
medication	Other
anxiety-related disorder	first-onset
anxiety-related disorder	hippocampal
anxiety-related disorder	psychotropics
anxiety-related disorder	reported
anxiety-related disorder	death
anxiety-related disorder	lithium
Prevention programme	Other
Aggression	Other
without	ECT
aggressive child	CYB5R3
education	Other
aggressive child	CYB5R3
pharmacotherapy	Other
approve thiol-containing redox modulatory compound	Other
its site	Other
we	Other
disabling condition	Other
patient	design
field	complement
appropriate clinical application	complement
appropriate clinical application	hippocampal
appropriate clinical application	stimulation
appropriate clinical application	psychotropics
appropriate clinical application	reported
appropriate clinical application	death
appropriate clinical application	mood
such treatment	first-onset
such treatment	hippocampal
such treatment	stimulation
such treatment	psychotropics
such treatment	reported
such treatment	death
such treatment	mood
numerous other neurostimulation modality	stimulation
common mental health problem	death
common mental health problem	mood
common mental health problem	lithium
